Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-infected”

2,479 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,479 results

Testing effectiveness (Phase 2)Study completedNCT00943540
What this trial is testing

Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients

Who this might be right for
HIV InfectionHIV Infections
Radboud University Medical Center 20
Not applicableStudy completedNCT00665561
What this trial is testing

Prospective Observational Epidemiologic Study of Maraviroc's Safety

Who this might be right for
Human Immunodeficiency Virus
ViiV Healthcare 2,500
Post-approval studies (Phase 4)Study completedNCT01138215
What this trial is testing

The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children

Who this might be right for
HIV InfectionsVaricella-zoster Virus
The HIV Netherlands Australia Thailand Research Collaboration 60
Large-scale testing (Phase 3)Study completedNCT00242840
What this trial is testing

Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 20
Large-scale testing (Phase 3)UnknownNCT00199979
What this trial is testing

Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients

Who this might be right for
Hiv Infection With Antiretroviral Therapy IndicationCD4 Below 350/µL or Below 15%
MEDEX 250
Testing effectiveness (Phase 2)Study completedNCT02588586
What this trial is testing

The Safety and Antiretroviral Activity of 3BNC117

Who this might be right for
HIV-1 Infection
Rockefeller University 17
Large-scale testing (Phase 3)Study completedNCT02489461
What this trial is testing

Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy

Who this might be right for
HIV-1-infection
Viriom 150
Not applicableStudy completedNCT01899196
What this trial is testing

Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients

Who this might be right for
Hiv Infection
ANRS, Emerging Infectious Diseases 24
Not applicableStudy completedNCT01634607
What this trial is testing

Bone Health and Vitamin D Status

Who this might be right for
OsteopeniaVitamin D DeficiencyHIV Infection
Thai Red Cross AIDS Research Centre 235
Large-scale testing (Phase 3)Study completedNCT00383734
What this trial is testing

Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
French National Agency for Research on AIDS and Viral Hepatitis 148
Early research (Phase 1)Study completedNCT03875209
What this trial is testing

10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults

Who this might be right for
HIV-1-infection
David Ho 54
Early research (Phase 1)Study completedNCT00000629
What this trial is testing

The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Not applicableStudy completedNCT00079729
What this trial is testing

Directly Observed Therapy in HIV Infected Adolescent Focus Groups

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableStudy completedNCT00000892
What this trial is testing

Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Not applicableStudy completedNCT00891644
What this trial is testing

Linkage to Care - Part II

Who this might be right for
HIVCare-seekingHIV Infections
University of North Carolina, Chapel Hill 59
Not applicableStudy completedNCT00001701
What this trial is testing

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection

Who this might be right for
Cryptococcosis
National Cancer Institute (NCI) 300
Early research (Phase 1)Study completedNCT00006509
What this trial is testing

The Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Not applicableStudy completedNCT03019601
What this trial is testing

Enhancing Uptake of Family Planning Services by HIV-Infected Women Attending the PMTCT Program

Who this might be right for
Contraception
Johns Hopkins University 3,300
Not applicableStudy completedNCT00046267
What this trial is testing

Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients

Who this might be right for
HIV InfectionsHypercholesterolemiaHypertriglyceridemia+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT02208167
What this trial is testing

Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy

Who this might be right for
HIV
University of North Carolina, Chapel Hill 6
Next Page